CNTX - CIK 0001842952
Context Therapeutics Inc. has filed 290 documents with the SEC between 2021 and 2026. The most frequent type is insider trade (63 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| SCHEDULE 13G/A | - | 2025-05-15 | - |
| SCHEDULE 13G/A | - | 2025-05-15 | - |
| Quarterly report | 10-Q | 2025-05-07 | 2025-03-31 |
| Annual report to shareholders | ARS | 2025-04-15 | 2024-12-31 |
| Proxy materials | DEFA14A | 2025-04-15 | - |
| Proxy statement | DEF 14A | 2025-04-15 | 2025-06-12 |
| Major company event | 8-K | 2025-04-09 | 2025-04-09 |
| PRE 14A | - | 2025-04-04 | 2025-06-12 |
| Employee stock plan | S-8 | 2025-03-20 | - |
| Annual report | 10-K | 2025-03-20 | 2024-12-31 |
| Major company event | 8-K | 2025-02-28 | 2025-02-27 |
| Insider trade | 4 | 2025-02-14 | 2025-02-13 |
| Insider trade | 4 | 2025-02-14 | 2025-02-13 |
| Insider trade | 4 | 2025-02-14 | 2025-02-13 |
| Insider trade | 4 | 2025-02-14 | 2025-02-13 |
| SCHEDULE 13G/A | - | 2025-02-14 | - |
| SCHEDULE 13G/A | - | 2025-02-14 | - |
| SCHEDULE 13G/A | - | 2025-02-14 | - |
| SCHEDULE 13G/A | - | 2025-02-14 | - |
| SCHEDULE 13G/A | - | 2025-02-12 | - |
| Insider trade | 4 | 2025-01-14 | 2025-01-13 |
| New insider ownership | 3 | 2025-01-14 | 2025-01-13 |
| Major company event | 8-K | 2025-01-14 | 2025-01-14 |
| Major company event | 8-K | 2025-01-13 | 2025-01-10 |
| SCHEDULE 13G | - | 2025-01-08 | - |
| Major company event | 8-K | 2024-12-23 | 2024-12-23 |
| Major company event | 8-K | 2024-12-02 | 2024-12-02 |
| Prospectus supplement | 424B5 | 2024-12-02 | - |
| EFFECT | - | 2024-11-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-14 | - |
| Passive ownership stake | SC 13G | 2024-11-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-14 | - |
| Company correspondence | CORRESP | 2024-11-12 | - |
| SEC correspondence | UPLOAD | 2024-11-12 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-11-06 | - |
| Quarterly report | 10-Q | 2024-11-06 | 2024-09-30 |
| Securities registration | S-3 | 2024-11-06 | - |
| Major company event | 8-K | 2024-09-23 | 2024-09-23 |
| Major company event | 8-K | 2024-09-17 | 2024-09-17 |
| Insider trade | 4 | 2024-09-05 | 2024-09-04 |
| New insider ownership | 3 | 2024-09-05 | 2024-09-04 |
| Insider trade | 4 | 2024-09-05 | 2024-09-04 |
| New insider ownership | 3 | 2024-09-05 | 2024-09-04 |
| Major company event | 8-K | 2024-09-04 | 2024-09-04 |
| Quarterly report | 10-Q | 2024-08-07 | 2024-06-30 |
| Insider trade | 4 | 2024-08-01 | 2024-08-01 |
| New insider ownership | 3 | 2024-08-01 | 2024-08-01 |
| Proxy materials | DEFA14A | 2024-07-24 | - |
| Proxy statement | DEF 14A | 2024-07-24 | 2024-09-17 |
| PRE 14A | - | 2024-07-12 | 2024-09-17 |